RhumbLine Advisers
CLPT icon

RhumbLine Advisers’s ClearPoint Neuro CLPT Stock Holding History

RhumbLine Advisers’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
33,857
+2,353
+7% +$29.4K ﹤0.01% 2645
2026
Q1 		$287K Buy
31,504
+60
+0.2% +$758 ﹤0.01% 2928
2025
Q4 		$430K Sell
31,444
-4,302
-12% -$79.7K ﹤0.01% 2764
2025
Q3 		$779K Sell
35,746
-1,903
-5% -$22.4K ﹤0.01% 2398
2025
Q2 		$450K Buy
+37,649
New +$474K ﹤0.01% 2747
2024
Q3 		– Sell
-5,759
Closed -$31K – 4223
2024
Q2 		$31K Sell
5,759
-16,443
-74% -$95.2K ﹤0.01% 3799
2024
Q1 		$151K Buy
22,202
+1,110
+5% +$7.76K ﹤0.01% 3300
2023
Q4 		$143K Sell
21,092
-9,265
-31% -$52.4K ﹤0.01% 3333
2023
Q3 		$152K Buy
30,357
+2,126
+8% +$12.7K ﹤0.01% 3303
2023
Q2 		$204K Buy
+28,231
New +$240K ﹤0.01% 3234
2022
Q2 		– Sell
-17,681
Closed -$184K – 3119
2022
Q1 		$184K Buy
17,681
+4,862
+38% +$44.3K ﹤0.01% 2776
2021
Q4 		$144K Sell
12,819
-334
-3% -$5K ﹤0.01% 2893
2021
Q3 		$233K Buy
13,153
+1,249
+10% +$23.4K ﹤0.01% 2852
2021
Q2 		$227K Buy
+11,904
New +$230K ﹤0.01% 2892

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

RhumbLine Advisers's CLPT Position: Q2 2026 in Review

RhumbLine Advisers increased its ClearPoint Neuro (CLPT) stake by 7.5% in Q2 2026, buying an estimated $29.4K and bringing the position to 33,857 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

RhumbLine Advisers first reported a position in CLPT in Q2 2021 and has held it in 14 quarters since. The position peaked at $779K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • RhumbLine Advisers held 33,857 shares of ClearPoint Neuro worth $604K as of Q2 2026.
  • RhumbLine Advisers bought 2,353 ClearPoint Neuro shares in Q2 2026, an estimated $29.4K.
  • ClearPoint Neuro made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2645 holding.
  • RhumbLine Advisers first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 14 quarters since.
  • RhumbLine Advisers's ClearPoint Neuro position peaked at $779K in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.